OpenVSafe by OpenVAERS
Search V-safe

KSH-30215-44362

3 vaccinations 7 coded responses 27 check-ins 6 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
106 / NY
Registered
2022-06-17
Relationship
Child or adolescent in my care
Guardian
26K-18816-76048
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-05-27
    Dose 1 — Pfizer-BioNTech
  2. 2022-06-17
    Registered in v-safe
  3. 2022-06-17
    Dose 2 — Pfizer-BioNTech
  4. 2022-06-17
    Health check-in — day 0, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  5. 2022-06-18
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Headache
    Adult check-in
  6. 2022-06-19
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-06-20
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-06-22
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2022-06-23
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2022-06-24
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-07-01
    Health check-in — day 14, dose 2, dependent
    Feeling: Good
    Adult check-in
  12. 2022-07-08
    Survey response — day 21, dose 2, dependent
    MedDRA: Abdominal pain, Headache — Feeling: Good
    Free text: Mild headache and tummy ache
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-07-15
    Health check-in — day 28, dose 2, dependent
    Feeling: Good
    Adult check-in
  14. 2022-07-22
    Health check-in — day 35, dose 2, dependent
    Feeling: Good
    Adult check-in
  15. 2022-07-29
    Survey response — day 42, dose 2, dependent
    MedDRA: Rhinorrhoea — Feeling: Good · Be unable to work or attend school
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-09-16
  17. 2022-11-06
    Dose 3 — Pfizer-BioNTech
    Co-administered: Flu
  18. 2022-11-07
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  19. 2022-11-08
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Site: Pain · None
    Adult check-in
  20. 2022-11-09
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  21. 2022-11-10
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · None
    Adult check-in
  22. 2022-11-11
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  23. 2022-11-12
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  24. 2022-11-13
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  25. 2022-11-20
    Survey response — day 14, dose 3, dependent
    MedDRA: Headache — Feeling: Fair
    Free text: Headache
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-11-27
    Survey response — day 21, dose 3, dependent
    MedDRA: Rhinorrhoea — Feeling: Fair
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-12-04
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  28. 2022-12-11
    Survey response — day 35, dose 3, dependent
    MedDRA: Rhinorrhoea — Feeling: Good
    Free text: Runny nose
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-12-19
    Survey response — day 42, dose 3, dependent
    MedDRA: Nausea, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Nausea, mild fever
    MedDRA releases: 2024-11 · check-in free text available
  30. 2023-02-05
    Survey response — 3 months, dose 3, dependent
    MedDRA: Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11
  31. 2023-05-07

Vaccinations

DoseDateManufacturerCo-administered
12022-05-27Pfizer-BioNTech No
22022-06-17Pfizer-BioNTech No
32022-11-06Pfizer-BioNTech Flu

Free text

Release 12 — day 21, dose 2, dependent

2022-07-08

Symptoms: Mild headache and tummy ache

Release 12 — day 42, dose 2, dependent

2022-07-29

Symptoms: Runny nose

Release 12 — day 14, dose 3, dependent

2022-11-20

Symptoms: Headache

Release 12 — day 21, dose 3, dependent

2022-11-27

Symptoms: Runny nose

Release 12 — day 35, dose 3, dependent

2022-12-11

Symptoms: Runny nose

Release 12 — day 42, dose 3, dependent

2022-12-19

Symptoms: Nausea, mild fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain · · ✓
SDHeadache · · ✓
SDNausea · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release